Stock Pick

If I wanted to outperform the ASX 200 over the next 10 years, I’d focus here

Written by

openjargon

in

Two smiling work colleagues discuss an investment at their office.

If my goal was simply to match the S&P/ASX 200 Index (ASX: XJO), I could just buy an index exchange-traded fund (ETF) and call it a day.

But if I genuinely want to outperform over the next decade, I think I need exposure to businesses with structural tailwinds, pricing power, and the ability to reinvest capital at high returns.

For me, that means leaning into quality, not speculation.

Here’s where I’d focus.

Structural growth in wealth management

One of the clearest long-term trends in Australia is the shift toward professional financial advice and platform-based wealth management.

That’s why I’d want exposure to Hub24 Ltd (ASX: HUB).

Funds under administration continue to grow as advisers migrate to more modern, feature-rich platforms. What excites me is the operating leverage. As scale builds, margins expand. Incremental flows are highly profitable.

If the company keeps executing, I believe earnings growth could exceed the broader market for years.

Global healthcare compounding

Healthcare is another area where I think long-term outperformance is possible.

ResMed Inc. (ASX: RMD) gives exposure to global demand for sleep and respiratory care. Ageing populations and increasing diagnosis rates create a long runway.

What I like most is the mix of hardware and high-margin software. Its cloud-connected ecosystem adds recurring revenue and stickiness.

If earnings keep compounding at attractive rates, I think the market will eventually reward that consistency.

High-margin niche technology

I also like niche technology leaders with strong competitive moats.

Pro Medicus Ltd (ASX: PME) is a good example. Its imaging software platform is used by leading hospitals globally, and switching costs are significant.

Concerns about artificial intelligence (AI) disruption have weighed on sentiment. But I think leading providers are more likely to integrate AI into their platforms than be displaced by it.

With long-term contracts, global expansion, and premium margins, this is the type of company I’d back to grow faster than the market over a decade.

Selective exposure to cyclicals with leverage

Outperformance of the ASX 200 index can also come from well-positioned cyclicals.

Qantas Airways Ltd (ASX: QAN) is one I’d consider for this bucket. Capacity discipline, a newer fleet, and strong loyalty economics have reshaped the business.

If management continues to execute well, earnings could remain strong even if conditions normalise.

The mindset that matters

For me, outperforming the ASX 200 is about owning businesses with durable advantages, letting them compound, adding capital during volatility rather than panicking.

There will be drawdowns. Some years will disappoint. But over 10 years, I think quality growth tends to win.

Foolish takeaway

If I genuinely want to beat the ASX 200 over the next decade, I’d focus on structural growth, global reach, and strong competitive positions.

Hub24, ResMed, Pro Medicus, and even selective cyclicals like Qantas represent the kind of mix I believe can outperform. Not every year, but over time.

The post If I wanted to outperform the ASX 200 over the next 10 years, I’d focus here appeared first on The Motley Fool Australia.

Should you invest $1,000 in HUB24 Limited right now?

Before you buy HUB24 Limited shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and HUB24 Limited wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys…

See the 5 Stocks

* Returns as of 20 Feb 2026

.custom-cta-button p {
margin-bottom: 0 !important;
}

More reading

Motley Fool contributor Grace Alvino has positions in Hub24. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Hub24 and ResMed. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended ResMed. The Motley Fool Australia has recommended Hub24 and Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More posts